http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ME-00706-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-121 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 1999-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba554f0ac89ae2e027be01e2be7fc5fa |
| publicationDate | 2007-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ME-00706-B |
| titleOfInvention | PHARMACEUTICAL COMPOSITION COMPRISING AN ENTACAPONE OR NITECAPONE, AS WELL AS A RETICULATED CELLULOSE DERIVATIVE |
| abstract | The present invention relates to an oral compacted composition comprising entacapone, nitecapone, or a pharmaceutically acceptable salt and cross-linked cellulose derivative thereof. The composition is based on the discovery that the cross-linked cellulose derivative increases the rate of release of entacapone or nitecapone from the oral compacted composition. Preferably, the amount of crosslinked cellulose derivative in the composition is at least 6% by weight, preferably from about 8% to about 16% by weight, by weight, especially from about 10% to about 14% by weight. The present invention relates to an oral compacted composition comprising entacapone, nitecapone, or a pharmaceutically acceptable salt and cross-linked cellulose derivative thereof. The composition is based on the discovery that the cross-linked cellulose derivative increases the rate of release of entacapone or nitecapone from the oral compacted composition. Preferably, the amount of crosslinked cellulose derivative in the composition is at least 6% by weight, preferably from about 8% to about 16% by weight, by weight, especially from about 10% to about 14% by weight. |
| priorityDate | 1998-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.